PROTEIN EXPRESSION AND CHARACTERIZATION OF THE MAJOR AUTOANTIGEN (TITIN DOMAIN) ASSOCIATED WITH AUTOIMMUNERIPPLING MUSCLE DISEASE

PROTEIN EXPRESSION AND CHARACTERIZATION OF THE MAJOR AUTOANTIGEN (TITIN DOMAIN) ASSOCIATED WITH AUTOIMMUNERIPPLING MUSCLE DISEASE

Bibliographic Details
Main Author:	Zelinka, Lisa M.
Language:	English
Published:	Kent State University / OhioLINK 2015
Subjects:	Biomedical Research Bioinformatics Autoimmune Rippling Muscle Disease Myasthenia Gravis Autoantibody Protein expression Protein Purification Genetic Manipulation of E coli
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=kent1416852571

Similar Items

Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child
by: Nils Erik Gilhus, et al.
Published: (2020-06-01)

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
by: Ruksana Huda
Published: (2020-02-01)

IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
by: Konstantinos Lazaridis, et al.
Published: (2020-11-01)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
by: Konstantinos Lazaridis, et al.
Published: (2020-02-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
by: Yung-Chuan Huang, et al.
Published: (2008-07-01)

Management of Juvenile Myasthenia Gravis
by: Karen O'Connell, et al.
Published: (2020-07-01)

Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
by: Miriam L. Fichtner, et al.
Published: (2020-05-01)

MYASTHENIA GRAVIS AS A RISK FACTOR DURING PREGNANCY
by: A. A. Borshcheva, et al.
Published: (2018-05-01)

Polymorphism of clinical phenotypes and heterogeneity of autoimmune targets of myasthenia gravis
by: Olena Klimova, et al.
Published: (2020-09-01)

Clinical characteristics of patients with myasthenia gravis associated with other autoimmune diseases
by: Li-li WANG, et al.
Published: (2014-10-01)

Is there an autoimmune basis for schizophrenia?
by: Abhinav Tewari, et al.
Published: (2017-01-01)

Enfermedades autoinmunes asociadas a la miastenia gravis en 217 pacientes timectomizados
by: Arnaldo González Zaldívar, et al.
Published: (1997-12-01)

Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis
by: Li‐Kai Tsai, et al.
Published: (2021-06-01)

Lyme hastalığı ve myasthenia gravis
by: Ahmet EVLİCE, et al.
Published: (2018-12-01)

Celiac disease and risk of myasthenia gravis – nationwide population-based study
by: Sujata P. Thawani, et al.
Published: (2018-03-01)

The dilemma of thymectomy in myasthenia gravis
by: Pushpendra Nath Renjen, et al.
Published: (2020-01-01)

Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment
by: Michelangelo Cao, et al.
Published: (2020-09-01)

The Clinical Outcome and Therapeutic Treatment of a Patient with Double Seronegative Myasthenia Gravis
by: Azanjac Ana, et al.
Published: (2014-03-01)

Antibodies to autoantigen targets in myasthenia and their value in clinical practice
by: S. I. Dedaev
Published: (2015-02-01)

Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells
by: Maria Zimmermann, et al.
Published: (2019-04-01)

Miastenia grave y miastenia grave ocular
by: Rosa María Naranjo Fernández, et al.

Disease severity assessment and short-term outcome in patients with myasthenia gravis
by: Deepthi Vemuri, et al.
Published: (2020-01-01)

Case Series: Clinical Impact of Plasmapheresis and Thymectomy on Early-Onset Myasthenia Gravis
by: Yusak M.T. Siahaan, et al.
Published: (2021-01-01)

Castleman′s disease with paraneoplastic pemphigus
by: Dinesha, et al.
Published: (2014-01-01)

Animal models of myasthenia gravis: utility and limitations
by: Mantegazza R, et al.
Published: (2016-03-01)

Frequency of familial occurrence and associated autoimmune diseases in a cohort of patients with acquired autoimmune myasthenia gravis from Belgrade
by: Josipović Maša, et al.
Published: (2017-01-01)

A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis
by: Victoria Leopardi, et al.
Published: (2021-06-01)

Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma
by: Vanessa M. Beutgen, et al.
Published: (2021-02-01)

Pediatric ocular myasthenia gravis: Case report and literature review
by: Adriana Solano, et al.
Published: (2019-01-01)

MYASTHENIA GRAVIS AND AUTOIMMUNE THYROID DISEASE
by: Tanja Hojs Fabjan, et al.
Published: (2001-12-01)

Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
by: Emma Frasson, et al.
Published: (2021-05-01)

Efficient purification and assembly of ribonucleoprotein complex for interaction analysis by MST assay coupled with GaMD simulations
by: Yunrong Gao, et al.
Published: (2021-03-01)

Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications
by: Kaori Noridomi, et al.
Published: (2017-04-01)

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
by: Laura Dresser, et al.
Published: (2021-05-01)

Thymectomy in 19 Cases of Myasthenia Gravis in 4 Years Follow up
by: Saeed Mahmoudi, et al.
Published: (2002-09-01)

The miracle of St. Alfege’s Hospital and the history of the treatment of myasthenia gravis
by: Cristina Croitoru, et al.
Published: (2017-03-01)

Diferentes formas de tratamiento en los pacientes miasténicos del grupo II-A
by: César Mustelier Fernández, et al.
Published: (1999-12-01)

MYASTHENIA GRAVIS IN PREGNANCY: A RARE ASSOCIATION WITH AN UNPREDICTABLE EVOLUTION – THREE CASES PRESENTATION
by: Benjilany Aboubakr, et al.
Published: (2021-06-01)

Diagnosis of sleepiness, fatigue and depression in patients with myasthenia gravis
by: O. A. Kreis, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_auto75qhe9ijqceuagb2illd3c